Aerpio Pharmaceuticals, Inc. ARPO
Set alert
2.20 +2.20 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 53.67M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -1.21
- Beta
- 1.65
- Short ratio
- 1.81
- Inst. own
- 71.05%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 11, 2021
- 50-d avg
- 31.63
- 200-d avg
- 25.85
- 1y target
- 22.00
Analyst view
Consensus: buy
Buy
Price target (mean) 22.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 1
- 2 months ago 1
- 3 months ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | -0.11 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | -0.12 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 2.87M | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 8, 2021 | HC Wainwright & Co. | Upgrade | Neutral | Buy |
| Dec 14, 2020 | HC Wainwright & Co. | Maintained | — | Neutral |
| Aug 13, 2020 | HC Wainwright & Co. | Maintained | — | Neutral |
| Jun 25, 2020 | HC Wainwright & Co. | Maintained | — | Neutral |
| Jun 12, 2019 | H.C. Wainwright | Initiated | — | Neutral |
| Mar 19, 2019 | H.C. Wainwright | Downgrade | Buy | Neutral |
| Mar 19, 2019 | Guggenheim | Downgrade | Buy | Neutral |
| Jan 18, 2019 | Cantor Fitzgerald | Initiated | — | Overweight |
| Sep 19, 2018 | Guggenheim | Initiated | — | Buy |
| Apr 18, 2018 | H.C. Wainwright | Initiated | — | Buy |